%20(2).jpg)
%20(1).jpg)
.jpg)
%20(1).jpg)
%20(1).jpg)
September 20, 2023
Ophthorobotics AG has won the innovator award at The European Society of Cataract and Refractive Surgeons (ESCRS)Ophthorobotics AG has won the innovator award at The European Society of Cataract and Refractive Surgeons (ESCRS)
Wet AMD is a form of late stage AMD characterized by abnormal blood vessel growth in the retina. Wt AMD progresses more rapidly than dry AMD.
Until recently, only wet AMD was treatable with anti-VEGF injections.
Dry AMD is the most common form of AMD. It is characterized by a slow and gradual degeneration of cells in the macula. Until recently dry AMD was untreatable. In 2023, FDA approval was granted for an intravitreal injection, that is slowing the advanced stage of the disease: Geographic atrophy. EMA approval is likely to follow and further compounds for geographic atrophy treatment are in late-stage development.
-min.webp)
Wet AMD is a form of late stage AMD characterized by abnormal blood vessel growth in the retina. Wet AMD progresses more rapidly than dry AMD
Until recently, only wet AMD was treatable with anti-VEGF injections.
Dry AMD is the most common form of AMD. It is characterized by a slow and gradual degeneration of cells in the macula. Until recently dry AMD was untreatable. In 2023, FDA approval was granted for an intravitreal injection, that is slowing the advanced stage of the disease: Geographic atrophy. EMA approval is likely to follow and further compounds for geographic atrophy treatment are in late-stage development.
AMD cases globally in 2023
geographic atrophy cases
wet AMD cases
Intravitreal injections are performed in a repetitive procedure. Surgeon time is used inefficiently, as they could perform more complex and higher value operations.
Human failures occure during stressful daily medical routine. Injecting the wrong patient eye, or drug happen. Reasons are that patients do not hear their name right, have the same name as another patient, or if both eyes need treatment at different times and dosages.
Patients experience discomfort due to a severe burning sensation during the desinfection of the eye and its surroundings, which is done prior to the injection.
Increasing pressure exists on reducing the compensation for intravitreal injections. Surgeons and hospitals struggle to manage an increased workload, while obtaining reduced reimbursement.
By providing a robotic injection system with an integrated local sterile environment and consumables to hospitals, we can increase safety for patients, decrease procedure times, allow for integrated data storage and documentation, reduce costs for medical staff and expensive operating rooms
By providing a robotic injection system with an integrated local sterile environment and consumables to hospitals, we can increase safety for patients, decrease procedure times, allow for integrated data storage and documentation, reduce costs for medical staff and expensive operating rooms
The system performs a fully automated AI-assisted injection which may also be initiated remotely. An iris scanner identifies the patient after which the OR-system uses a disposable sterilizing patch to locally disinfect the injection area. The injection is then performed with continuous eye tracking for automated precision and ocular alignment.
Injections are run in a local sterile environment above the patient's face to decrease the chance of infections and account for patient safety. The system runs automated and the injection is AI-assisted teleoperated by the surgeon. The injection is held in a local sterile environment with electronic patient record. The process looks as followed:
A nurse prepares the patient for injection.
The sytem is coarsely positioned over the patient's head, followed by automated fine positioning.
An iris scan identifies the patient and eye and the injection point is specified.
A nurse prepares the patient for injection.
The process is completed by automated data documentation
Patients are treated remotely with AI enabled diagnostics. Electronic patient records are integrated in the system.
Burning sensations are ameliorated. The disinfection area is significantly reduced, enabling a faster procedure.
The patient is identified through an iris scan and the eyes are continously tracked. This enables safe and reliable injections.
Less labor time is required so surgeon time can be used more efficiently. No expensive operating rooms are required.
Patients are treated remotely with AI enabled diagnostics. Electronic patient records are integrated in the system.
Burning sensations are ameliorated. The disinfection area is significantly reduced, enabling a faster procedure.
The patient is identified through an iris scan and the eyes are continously tracked. This enables safe and reliable injections.
Less labor time is required so surgeon time can be used more efficiently. No expensive operating rooms are required.
We believe in the best talent, irrespective of location. Our teams works as a global network of expertise and passion for healthcare.
.jpg)
Legal Advisor
September 20, 2023
Ophthorobotics AG has won the innovator award at The European Society of Cataract and Refractive Surgeons (ESCRS)Ophthorobotics AG has won the innovator award at The European Society of Cataract and Refractive Surgeons (ESCRS)
July 10, 2023
Ophthorobotics Strengthens Patent Position For Its Lead Product IIDOphthorobotics, a preclinical-stage medtech company developing a first in class automated intravitreal injection system , announced today that it was granted a key patent for its unique drug delivery system by the european patent office (EPO).
February 28, 2023
New Chairman of the Board appointedOphthorobotics Appoints Bernhard Günther as Chairman of the Board of Directors
